Results 11 to 20 of about 38,617 (240)

Targeting the Mevalonate Pathway in Cancer

open access: yesTrends in Cancer, 2021
The mevalonate synthesis inhibitors, statins, are mainstay therapeutics for cholesterol management and cardiovascular health. Thirty years of research have uncovered supportive roles for the mevalonate pathway in numerous cellular processes that support oncogenesis, most recently macropinocytosis. Central to the diverse mechanisms of statin sensitivity
Juarez, Dennis, Fruman, David A
openaire   +6 more sources

Marine <i>Flavobacteriaceae</i> produce zeaxanthin via the mevalonate pathway. [PDF]

open access: yesMar Life Sci Technol
Zeaxanthin, an oxygenated carotenoid derivative with potent antioxidative properties, is produced by many organism taxa. Flavobacteriaceae are widely distributed in marine environments; however, the zeaxanthin biosynthesis property in this family remains incompletely explored.
Chen Y   +8 more
europepmc   +3 more sources

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. [PDF]

open access: yesCancer Cell, 2023
Zhou W   +20 more
europepmc   +2 more sources

The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA

open access: yesGenes and Diseases, 2022
Osteosarcoma is the most common malignant bone tumour, and the metastasis of osteosarcoma is an important cause of death. Evidence has shown that the mevalonate pathway is highly activated and is expected to be a new target for tumour therapy.
Xing Du   +5 more
doaj   +1 more source

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

open access: yesHepatology, EarlyView., 2022
Hepatic APOF transcript levels correlate inversely with plasma TG and hepatic steatosis in humans. ApoF expression in mice promotes VLDL‐TG production and lipoprotein remnant clearance in mice. Abstract Background NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD,
Audrey Deprince   +30 more
wiley   +1 more source

Glucose restriction drives spatial reorganization of mevalonate metabolism

open access: yeseLife, 2021
Eukaryotes compartmentalize metabolic pathways into sub-cellular domains, but the role of inter-organelle contacts in organizing metabolic reactions remains poorly understood.
Sean Rogers   +4 more
doaj   +1 more source

Statin-induced myopathic changes in primary human muscle cells and reversal by a prostaglandin F2 alpha analogue [PDF]

open access: yes, 2020
Statin-related muscle side effects are a constant healthcare problem since patient compliance is dependent on side effects. Statins reduce plasma cholesterol levels and can prevent secondary cardiovascular diseases.
Dittmar, Gunnar   +10 more
core   +1 more source

Evidence for an underestimation of the shunt pathway of mevalonate metabolism in slices of livers and kidneys from fasted rats and rats in diabetic ketosis

open access: yesJournal of Lipid Research, 1982
Yields of (14)CO(2) from [2-(14)C]mevalonate and [5-(14)C]mevalonate have been used by others to estimate the activity of the non-sterol-forming pathway, also called the mevalonate shunt pathway, and yields of (14)C in sterols have been used to estimate ...
P S Brady   +4 more
doaj   +1 more source

Impact of Sex and Age on the Mevalonate Pathway in the Brain: A Focus on Effects Induced by Maternal Exposure to Exogenous Compounds

open access: yesMetabolites, 2020
The mevalonate pathway produces cholesterol and other compounds crucial for numerous cellular processes. It is well known that age and sex modulate this pathway in the liver.
Claudia Tonini   +2 more
doaj   +1 more source

An Adaptation To Life In Acid Through A Novel Mevalonate Pathway. [PDF]

open access: yes, 2016
Extreme acidophiles are capable of growth at pH values near zero. Sustaining life in acidic environments requires extensive adaptations of membranes, proton pumps, and DNA repair mechanisms.
Bowie, James U   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy